BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  Bausch Health to Announce Fourth-Quarter and Full-Year 2022 Results on Feb. 23

  Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release its fourth-quarter and full-year financial results on Thursday, Feb. 23, 2022.

  February 1, 2023

   · 

  1 min read
• BioMidwest

  Integrated DNA Technologies Expands Access, Expedites Turnaround Time, for Minimal Residual Disease (MRD) Solutions for Cancer Research

  Integrated DNA Technologies Expands Access, Expedites Turnaround Time, for Minimal Residual Disease (MRD) Solutions for Cancer Research.

  February 1, 2023

   · 

  4 min read
• Deals

  Ensysce Biosciences Announces the Distribution of Series A Preferred Stock to Holders of Its Common Stock

  Ensysce Biosciences, Inc. today announced that its Board of Directors has declared a dividend of 0.001 of a share of newly-designated Series A Preferred Stock, par value $0.0001 per share.

  February 1, 2023

   · 

  5 min read
• Drug Development

  Edesa Biotech Receives Regulatory Approval for Phase 2 Vitiligo Study

  Edesa Biotech, Inc. today announced that it has received approval from Health Canada for a Phase 2 clinical study of the company’s EB06 monoclonal antibody candidate as a treatment for vitiligo.

  February 1, 2023

   · 

  5 min read
• Biotech Beach

  Pardes Biosciences to Present at SVB Securities Global Biopharma Conference

  Pardes Biosciences, Inc. announced that management will participate in a fireside chat at the SVB Securities Global Biopharma Conference on Tuesday, February 14, 2023 at 10:40 a.m. PT / 1:40 p.m. ET.

  February 1, 2023

   · 

  1 min read
• Pharm Country

  Lisata Therapeutics Announces Participation in Upcoming Conferences in February

  Lisata Therapeutics, Inc. today announced that management will present at two upcoming conferences.

  February 1, 2023

   · 

  2 min read
• Pharm Country

  ResolutionRx Ltd, a wholly owned subsidiary of RespireRx Pharmaceuticals Inc. Enters into LOI and Term Sheet with Radium Capital for the financing of anticipated Research and Development Credits

  RespireRx Pharmaceuticals Inc. is pleased to announce that, on January 27, 2023, ResolutionRx Ltd, a newly formed Australian unlisted public company, and initially, a wholly-owned subsidiary of RespireRx, entered into a Letter of Intent and Term Sheet with Radium Capital.

  February 1, 2023

   · 

  15 min read
• Genetown

  Ratio Therapeutics Announces $20M Series A Financing to Advance Targeted Radiotherapies for Cancer Treatment

  Ratio Therapeutics Inc. announces the close of its Series A financing extension today, bringing the total raised to date to over $40 million.

  February 1, 2023

   · 

  4 min read
• Pusan National University Researchers Uncover Novel Gene That Regulates Leukemia Development and Progression

  Leukemia, a type of blood cancer, affected around 2.3 million people around the world in 2015.

  February 1, 2023

   · 

  3 min read
• Biotech Beach

  DCN Dx and Mapp Biopharmaceutical Announce Subcontract

  DCN Dx announced a subcontract with Mapp Biopharmaceutical, Inc., a developer of novel pharmaceuticals for the prevention and treatment of infectious diseases, focusing on unmet needs in global health and biodefense.

  February 1, 2023

   · 

  3 min read